2021 was a difficult year even for the billionaires of the world. In the annual Forbes ranking of the richest people in the world this year, there are 87 fewer than a year ago. And they are collectively worth $12.7 trillion, down $400 billion from 2021.
Although the amount of billionaires worldwide fell, 40% of those left behind got richer, Forbes reported.
More than 200 health care executives are now in the “three comma club”
The United States still leads the world, with 735 billionaires collectively worth $4.7 trillion, including Elon Musk, who tops the list of billionaires in the world for the first time with a staggering net worth of $219 billion. Forbes used the share prices and exchange rates as of March 11, 2022 to calculate net worth, the publication reported.
More than 200 health care executives, 217 to be exact, are now in the “three comma club”as Forbes calls it, and are among the 2,668 billionaires on Forbes’ 2022 list.
One person notably absent from the global list was Judy Faulkner, founder of medical record systems company Epic. He was ranked 147th in Forbes’ 2021 ranking of America’s 400 Richest People with a net worth of $6.5 billion.
Usually, Cyrus Poonawalla, chairman of the Poonawalla Group, topped the list as the world’s richest health care executive. The Poonawalla Group includes the Serum Institute of Indiathe main company of biotechnology India and the world’s largest vaccine manufacturer by number of doses, according to Forbes.
The net worth of poonawalla it has been $24.3 billion, ranking it 56th.
WHO FOLLOWED HIM?
List of the MOST billionaires in health care this 2022
Thomas Frist Jr., MD, and family
frist founded Hospital Corporation of America with his father in 1968. The healthcare system expanding publicly traded and operates 187 hospitals and about 2,000 care sites in 20 US states and the UK Frist Jr. does not have an executive position at HCA, but his sons, Thomas Frist III and William Frist, are members of the board.
- Forbes Rating: 73
- 2022 net worth: $21.3 billion vs. $15.7 billion in 2021
Carl Cook
Cook is the CEO of the medical device maker Cook Group, a business his parents started in their Bloomington, Indiana, apartment in 1963. $2.5 billion company it sold one of its subsidiaries, Cook Pharmica, to drug delivery technology company Catalent for $950 million in 2017.
- Forbes Rating: 177
- 2022 net worth: $11.7 billion vs. $9.9 billion in 2021
Li Ge, Ph.D.
Ge co-founded and chairs WuXi AppTeca global R&D and manufacturing services company supporting the pharmaceutical, biotech and medical device industries.
- Forbes Rating: 235
- 2022 net worth: $8.8 billion down from $10.1 billion in 2021
Dr. Patrick Soon-Shiong
The transplant surgeon Patrick Soon-Shiong invented the cancer drug Abraxane. Soon-Shiong has taken four companies public. Including IPO of cancer drug maker NantKwest in 2015 and its biotech start-up NantHealth public in 2016.
It sold its pharmaceutical companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion. he owns NantWorksa network of new health companies, ImmunityBio and has stakes in media firm Tribune Publishing and the Los Angeles Lakers. He bought the Los Angeles Times and the San Diego Tribune for $500 million in June 2018.
- Forbes Rating: 324
- 2022 net worth: $7.3 billion down from $7.5 billion in 2021
Reinhold Schmiding
Reinhold Schmiding is the founder and CEO of ArthrexA company of orthopedic surgical tools. The company has developed more than 13,000 products used in shoulder, hip and other orthopedic surgeries. The private company has estimated revenues of $2.6 billion, and Schmieding owns more than 90% of the company.
- Forbes Rating: 330
- 2022 net worth: $7.2 billion vs. $6.7 billion in 2021
Meet the full list here
Related Notes: